Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ZR2 BioenergyBOM:506640 28 Return-on-Tangible-Asset is 0.62% as of Jun. 2026, which is 182% above its 10-year median of 0.22. GuruFocus rates BOM:506640 with a GF Score™ of 28/100. The stock has 1 warning sign investors should review. Among 1,617 Chemicals companies, ZR2 Bioenergy ranks worse than 71.18% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. ZR2 Bioenergy's annualizedNet Income for the quarter that ended in Jun. 2026 was ₹8.80 Mil. ZR2 Bioenergy's average total tangible assets for the quarter that ended in Jun. 2026 was ₹1,413.08 Mil. Therefore, ZR2 Bioenergy's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 0.62%.
The historical rank and industry rank for ZR2 Bioenergy's Return-on-Tangible-Asset or its related term are showing as below:
BOM:506640'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -10.58 Med: 0.22 Max: 9.09
Current: 0.65
During the past 13 years, ZR2 Bioenergy's highest Return-on-Tangible-Asset was 9.09%. The lowest was -10.58%. And the median was 0.22%.
BOM:506640's Return-on-Tangible-Asset is ranked worse than 71.18% of 1617
companies
in the Chemicals industry
Industry Median: 3.62
vs BOM:506640: 0.65
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
ZR2 Bioenergy Return-on-Tangible-Asset Related Terms
ZR2 Bioenergy Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for ZR2 Bioenergy's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:506640 vs DOW: Return-on-Tangible-Asset Comparison
For the Chemicals subindustry, ZR2 Bioenergy's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ZR2 Bioenergy Return-on-Tangible-Asset vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, ZR2 Bioenergy's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where ZR2 Bioenergy's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 0.62% mean?
ZR2 Bioenergy (BOM:506640) has a Return-on-Tangible-Asset of 0.62% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on ZR2 Bioenergy and its competitors. This is 182% above median its historical median of 0.22. According to the industry distribution chart, ZR2 Bioenergy ranks #1151 out of 1617 companies in the Chemicals industry, placing it in the top 71.2%.
Is ZR2 Bioenergy's Return-on-Tangible-Asset too high?
ZR2 Bioenergy's current Return-on-Tangible-Asset of 0.62% is 182% above median its 10-year median of 0.22. The Chemicals industry median Return-on-Tangible-Asset is 3.62. ZR2 Bioenergy's value of 0.62% is 82.9% below this industry median. Based on the distribution chart, ZR2 Bioenergy ranks #1151 out of 1617 companies in the Chemicals industry, which is below the industry midpoint. Overall, ZR2 Bioenergy has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does ZR2 Bioenergy's Return-on-Tangible-Asset compare to DOW?
According to the Chemicals industry distribution chart, ZR2 Bioenergy ranks #1151 out of 1617 companies for Return-on-Tangible-Asset. This places ZR2 Bioenergy in the lower half of its industry. The industry median Return-on-Tangible-Asset is 3.62. ZR2 Bioenergy's value of 0.62% is 82.9% below this benchmark. While the company's 10-year median is 0.22 vs. the industry median of 3.62, ZR2 Bioenergy has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Chemicals company?
The median Return-on-Tangible-Asset among Chemicals companies is 3.62, based on 1,617 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ZR2 Bioenergy's current Return-on-Tangible-Asset of 0.62% is 82.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on ZR2 Bioenergy and its competitors. For the Chemicals industry, the median Return-on-Tangible-Asset is 3.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ZR2 Bioenergy's current Return-on-Tangible-Asset is 0.62%, which is 182% above median its own 10-year median of 0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ZR2 Bioenergy stock overvalued right now?
ZR2 Bioenergy (BOM:506640) has a current Return-on-Tangible-Asset of 0.62%. The current Return-on-Tangible-Asset is 0.62%, which is 182% above median its 10-year median of 0.22 and 82.9% below the Chemicals industry median of 3.62. ZR2 Bioenergy's overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For ZR2 Bioenergy (BOM:506640), the current Return-on-Tangible-Asset is 0.62% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ZR2 Bioenergy Ltd is a chemical company. Its product portfolio includes Ethanol, Compressed Biogas, Bio-Potash, Carbon Credits, Alternative Protein, and a variety of human and animal nutrition products.
28GF Score
Get the complete analysis for BOM:506640
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:506640 has been successfully added to your 
